Did you know?
ChinaBio® LLC is a consulting and advisory firm that helps Western companies come to China. We assist our clients with China strategy development, market research and analysis, partner/technology searches, competitive surveys, and market entry planning.

>> Learn more…
Site Search

>> Advanced Search

  Quick Search:
 
 

Free Newsletter

  Email address:
   

Shanghai Pharma Spending to Build Drug Distribution Business

publication date: Jul 13, 2011
View a Printer Friendly version of this page, allowing you to print the page. Send a summary of this page to someone via email.
Shanghai Pharmaceutical Holding plans to make a 2 billion RMB ($310 million) capital expenditure that will, among other things, solidify its drug distribution business in North China. The company will put 1 billion RMB ($155 million) of capital in its distribution subsidiary to bulk up its sales network. Another $80 million will go to establish a sales unit in North China, and it will spend 500 million RMB ($75 million) in an information technology venture. More details....

Stock Symbol: (SHA: 601607)     Share this with colleagues:  

 


This article is available for purchase - please click here for details.


Sorry... this feature or article is only available to subscribers.

>> Learn more about our subscription plans...

>> Free email newsletter...

>> Login...

Login

  

    
   
Partner Events

China Medical Affairs Summit
June 12-13, 2014
Shanghai, China


>>More events...
Our Partners
Annual Sponsors
 
Official Partners
 
Supporting Partners
 
Media Partners